SLXN   $1.9300000000000002  -8.10% Market Closed

Silexion Therapeutics Corp
Total Cash 2.78M
totalCashPerShare 11.102
EBITDA -1.35M
Total Debt 144.00K
quickRatio 3.639
currentRatio 3.851
Total Revenue
debtToEquity 8.944
Revenue/Share
ROA -0.62134
ROE -1.16659
grossProfits
freeCashflow -305.62K
operatingCashflow -794.00K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 15.85M
forwardPE
floatShares
sharesOutstanding 13.83M
sharesShort 88.97K
sharesShortPriorMonth 206.51K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.34%
heldPercentInstitutions 0.09%
Short Ratio help_outline 0.02%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -67.136
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -1.35M
trailingEps -0.66%
forwardEps
enterpriseToEbitda -11.70
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 9
lastUpdated Nov. 2, 2024, 7:57 a.m.